Best Vascular Inc. specializes in vascular brachytherapy, radiation therapy delivered inside a blood vessel to prevent restenosis following balloon angioplasty, using the Beta-Cath system.
The Beta-Cath is commercially available in the U.S., European Union, Canada and other countries.
The Beta-Cath System is primarily used to treat patients suffering from “in-stent” restenosis, a condition in which coronary stents become blocked with new tissue growth. It is estimated about 150,000 patients in the U.S. need treatment for this condition annually. Novoste has also initiated clinical trials to investigate the role of vascular brachytherapy to treat peripheral arterial disease and arterial-venous dialysis graft stenosis.
August 2008
April 10, 2026 
